Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 24

1.
2.

Gadolinium use in patients with kidney disease: a cause for concern.

Perazella MA, Rodby RA.

Semin Dial. 2007 May-Jun;20(3):179-85. Review.

PMID:
17555477
3.

Gadolinium and nephrogenic systemic fibrosis.

Grobner T, Prischl FC.

Kidney Int. 2007 Aug;72(3):260-4. Epub 2007 May 16. Review.

4.

Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.

Pedersen M.

J Magn Reson Imaging. 2007 May;25(5):881-3. No abstract available.

PMID:
17457808
5.
6.

Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Kaneshiro TL, Ke T, Jeong EK, Parker DL, Lu ZR.

Pharm Res. 2006 Jun;23(6):1285-94. Epub 2006 Jun 1.

PMID:
16729223
7.

Future directions in body magnetic resonance imaging.

Hyslop WB, Semelka RC.

Top Magn Reson Imaging. 2005 Feb;16(1):3-14. Review.

PMID:
16314694
8.

PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.

Mohs AM, Zong Y, Guo J, Parker DL, Lu ZR.

Biomacromolecules. 2005 Jul-Aug;6(4):2305-11.

PMID:
16004476
9.
10.

Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.

Zong Y, Wang X, Goodrich KC, Mohs AM, Parker DL, Lu ZR.

Magn Reson Med. 2005 Apr;53(4):835-42.

11.

Targeted contrast agents for magnetic resonance imaging and ultrasound.

Morawski AM, Lanza GA, Wickline SA.

Curr Opin Biotechnol. 2005 Feb;16(1):89-92. Review.

PMID:
15722020
12.

PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.

Mohs AM, Wang X, Goodrich KC, Zong Y, Parker DL, Lu ZR.

Bioconjug Chem. 2004 Nov-Dec;15(6):1424-30.

PMID:
15546211
13.

Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.

Lu ZR, Parker DL, Goodrich KC, Wang X, Dalle JG, Buswell HR.

Magn Reson Med. 2004 Jan;51(1):27-34.

14.

3D MR angiography of intratumoral vasculature using a novel macromolecular MR contrast agent.

Kobayashi H, Sato N, Kawamoto S, Saga T, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW.

Magn Reson Med. 2001 Sep;46(3):579-85.

15.

Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging.

Weissleder R, Bogdanov A Jr, Tung CH, Weinmann HJ.

Bioconjug Chem. 2001 Mar-Apr;12(2):213-9.

PMID:
11312682
16.

Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates.

Duarte MG, Gil MH, Peters JA, Colet JM, Elst LV, Muller RN, Geraldes CF.

Bioconjug Chem. 2001 Mar-Apr;12(2):170-7.

PMID:
11312677
17.

Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.

Ladd DL, Hollister R, Peng X, Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Eck J, Desai VC, Raymond G, Kinter LB, Desser TS, Rubin DL.

Bioconjug Chem. 1999 May-Jun;10(3):361-70.

PMID:
10346865
19.

Enhanced liver MR: contrast agents and imaging strategy.

Runge VM, Kirsch JE, Wells JW, Awh MH, Bittner DF, Woolfolk CE.

Crit Rev Diagn Imaging. 1993;34(1-2):1-30. Review.

PMID:
8216813
20.

Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents.

Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC.

Magn Reson Med. 1994 Jan;31(1):1-8.

PMID:
8121264

Supplemental Content

Support Center